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Abstract
Background: Chromobacterium violaceum is a Gram negative facultative anaerobic bacillus, found
in soil and stagnant water, that usually has a violet pigmented appearance on agar culture. It is rarely
described as a human pathogen, mostly from tropical and subtropical areas.
Case presentation: A 53 year-old farmer died with Chromobacterium violaceum septicemia in
Laos. A modified oxidase method was used to demonstrate that this violacious organism was
oxidase positive. Forensic analysis of the glucose-6-phosphate dehydrogenase genotypes of his
family suggest that the deceased patient did not have this possible predisposing condition.
Conclusion: C. violaceum infection should be included in the differential diagnosis in patients
presenting with community-acquired septicaemia in tropical and subtropical areas. The apparently
neglected but simple modified oxidase test may be useful in the oxidase assessment of other violet-
pigmented organisms or of those growing on violet coloured agar.
Background
Chromobacterium violaceum is a Gram negative facultative
anaerobic bacillus, found in soil and stagnant water, that
usually has a violet pigmented appearance on agar cul-
ture. Since its discovery as a human pathogen in 1927 in
Malaysia [1] only ~150 human cases have been reported
worldwide, mostly from tropical and subtropical areas. C.
violaceum  septicaemia has been described in Thailand,
with two patients from a province adjacent to Laos [2] and
Vietnam [3,4] but, to our knowledge, this is the first
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patient described in Laos. The disease typically starts with
a localized skin infection or localized lymphadenitis after
contact with stagnant water or soil and progresses to ful-
minating septicaemia with necrotizing metastatic lesions
and multiple abscesses in the liver, lung, spleen, skin,
lymph nodes, and brain, resulting in fatal multiorgan fail-
ure [1-10]. The mortality from disseminated C. violaceum
infection has been reported to be 60–80% [1-10]. How-
ever, the optimal treatment has not been established –
combination therapy with co-trimoxazole, chloramphen-
icol, carbapenems, or fluoroquinolones has been sug-
gested [2,7,9]. Resistance to penicillins and
cephalosporins has been commonly reported [3,9,11]
and makes therapy while microbiology results are awaited
difficult as both antibiotics are commonly used for empir-
ical therapy of septicemia.
Case presentation
A 53-year-old Tai Dam [12] Lao farmer was admitted in
August 2008 at the Provincial Hospital of Luang Namtha,
northern Lao PDR (Laos), with 2 days of fever, chills,
severe headaches, nausea and vomiting, and a cough pro-
ductive of white sputum. He had been healthy apart from
serious leg injuries from a relict bomb explosion 6 years
previously. On admission he was alert and orientated,
normotensive, without neck stiffness, abdominal tender-
ness, lymphadenopathy, hepatosplenomegaly, pallor or
jaundice but was febrile (39.7°C) with crepitations audi-
ble at the left lung base. He had no rash but old scars on
his thighs from the bomb injury and minor scars on his
lower legs and flanks from insect bites. He was not known
to contain shrapnel. With suspected community-acquired
pneumonia he was started on oral amoxicillin (1 g twice
daily) and paracetamol. With an increase of his fever to
40.2°C, metamizole (1 g twice daily IV) was added. On
day 2 his full blood count showed normochromic anae-
mia (Hct 18%, Hb 6 g/dL, MCHC 33 g/dL, leucocytes 7.5
109/L, neutrophils 70%, lymphocytes 30%). Malaria
smear and HRP-2 rapid test for Plasmodium falciparum
malaria (Paracheck™, Orchid Industries, Goa, India) were
negative. An abdominal ultrasound demonstrated a dif-
fuse enlarged liver, without focal lesions, and mild
splenomegaly. A chest radiograph showed a slightly
enlarged heart but no infiltrations. The patient developed
upper abdominal and lower back pain and increasing dys-
pnoea and was pale and jaundiced with a respiratory rate
of 42/min, temperature 39°C, blood pressure 90/60
mmHg, heart rate irregular 120/min, bibasal inspiratory
crepitations, tender hepatomegaly (1 cm below costal
margin in mid-clavicular line) with axillary and inguinal
lymphadenopathy. As community-acquired septicaemia
or leptospirosis were suspected, therapy was changed to
ceftriaxone (1 g twice daily) and he was given a blood
transfusion. However, he deteriorated with worsening
abdominal pain and distension, dyspnoea, central cyano-
sis with cold extremities, coma (GCS 7/15) and a dissem-
inated maculopapular rash with petechiae on arms and
trunk and prolonged bleeding at intravenous injection
sites. On day 3 he became apnoeic and could not be resus-
citated.
Blood cultures from admission and day 2, sent by plane to
Vientiane [13,14], grew Chromobacterium violaceum (Gram
negative rods, catalase positive, Voges-Proskauer test neg-
ative, violacious colour on agar, API 20 NE (bioMerieux,
France) 99.3% agreement). As the C. violaceum were pig-
mented violet conventional oxidase tests could not be
interpreted and the ingenious but apparently neglected
method of Dhar & Johnson [15] was used to demonstrate
that the organism was oxidase positive (Fig. 1). The organ-
ism was sensitive to gentamicin, chloramphenicol,
ofloxacin, ciprofloxacin, co-trimoxazole, imipenem, and
resistant to ampicillin, ceftriaxone, and ceftazidime by
disc diffusion testing (using NCCLS criteria for Vibrio or
Enterobacteracea). Etest (AB Biodisk, Solna, Sweden)
demonstrated MICs of 0.023, 4 and >32 ug/L against
ofloxacin, chloramphenicol and ceftriaxone, respectively.
After his death his family was re-interviewed regarding
possible risk factors. He had been pale with mild jaundice
since childhood and when aged ~12 years was said to have
had a big spleen. One week before the onset of fever he
had gone to rice fields and fishing and slept at a market
where he noted an axillary leech. The bite wound did not
become overtly infected.
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
has been suggested as a risk factor for C. violaceum infec-
tion [7,16] but the aetiological diagnosis was only made
after the patient's death and no blood samples were avail-
able for G6PD testing. Therefore, with their informed con-
sent, his wife and 4 daughters were tested for G6PD
deficiency, using finger prick blood samples on filter
paper, by quantitative spectrophotometric analysis (WST-
8 method [17]) and sequencing of the G6PD gene in the
X-chromosome [18]. The patient's wife and 3 of the 4
tested daughters had a substitution of G to A at the 1388
position in G6PD gene, signifying carriage of G6PD Kaip-
ing. Since one of the daughters had wild type X-chromo-
somes with normal G6PD activity the patient evidently
did not have G6PD deficiency.
Our patient did not have a primary skin infection. How-
ever, he had a leech bite a week before onset of fever
which may or not have been significant – as far as we are
aware this organism has not been described from the
leech gastrointestinal tract. The patient's striking anaemia,
severe abdominal and lower back pain, tachycardia, and
jaundice in combination with a history of pallor and
splenomegaly in childhood could be explained by an
acute intravascular haemolysis due to underlying G6PDAnnals of Clinical Microbiology and Antimicrobials 2009, 8:24 http://www.ann-clinmicrob.com/content/8/1/24
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Oxidase test adapted from Dhar & Johnson [15] Figure 1
Oxidase test adapted from Dhar & Johnson [15]. Smears (arrows) of organisms were applied to two Whatman 3 M fil-
terpapers folded, vertically, into three. The filter papers were placed vertically in Petri dishes so that the solution within soaked 
vertically across the smears of organisms. Top panel: filterpaper stood in 10 ml distilled water in a Petri dish, bottom panel: fil-
terpaper stood in 10 ml 1% aqueous solution of N, N, N', N'-tetramethyl-1, 4-phenylene-diamine dihydrochloride (Fluka 
87890, Czech Republic) in a Petri dish. The organisms smeared were left E. coli ATCC 25922 (negative control), centre C. viol-
aceum isolate from patient and right P. aeruginosa ATCC 27853 (positive control). Water (top panel) failed to produce any 
streaks whilst N,N,N',N'-tetramethyl-1, 4-phenylene-diamine dihydrochloride (bottom panel) led to pronounced vertical 
flame-like streaks across smears of C. violaceum and P. aeruginosa within 5 minutes, indicating oxidase test positivity. The flame-
like streaks had faded by the next day. The profound violet color of the C. violaceum smear is clearly visible.Annals of Clinical Microbiology and Antimicrobials 2009, 8:24 http://www.ann-clinmicrob.com/content/8/1/24
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deficiency, possibly precipitated by metamizole (dipy-
rone), which is contraindicated in G6PD deficiency [19].
Laos has a high prevalence of G6PD deficiency (15–26%
of males hemizygous [20,21]). In view of G6PD being a
possible risk factor for both his infection and haemolysis
we performed forensic analysis of the surviving members
of his family. However, this demonstrates, assuming cor-
rect blood relationships, that he could not have had
G6PD deficiency. G6PD Kaiping is a common mutation
in neighboring China [22].
Melioidosis (Burkholderia pseudomallei) is a common and
frequently fatal condition in Northeast Thailand and the
M e k o n g  v a l l e y  o f  L a o s  [ 1 4 ]  b u t  h a s ,  s o  f a r ,  n o t  b e e n
described from the highlands of northern Laos and it may
not occur in the soil there. C. violaceum and melioidosis
resemble each other with reservoirs in soil and water, clin-
ical presentation, resistance to antibiotics commonly used
to empirically treat septicaemia, high mortality and the
need for prolonged oral antibiotic eradication therapy.
However, as C. violaceum is frequently resistant to cepha-
losporins, such as ceftazidime [5,9], commonly used to
treat melioidosis, awareness of C. violaceum as an alterna-
tive diagnosis is important [2]. The two organisms can be
confused in the laboratory and both are oxidase positive
[23]. The ingenious method of Dhar & Johnson [15] was
used to determine the oxidase status of the organism –
this apparently neglected but simple technique may be
useful in the oxidase assessment of other violet-pig-
mented organisms or of those growing on violet colored
agar. A similar method was described [24] after that of
Dhar & Johnson [15]. Conventional oxidase testing of
very young or anaerobic C. violaceum cultures, which are
usually non-pigmented, have also been used but the evi-
dence available suggests that they may not be accurate
[6,24].
Conclusion
C. violaceum infection should be included in the differen-
tial diagnosis of patients presenting with community-
acquired septicaemia in tropical and subtropical areas,
especially with a history of contact with soil and stagnant
water, and is an important alternative diagnosis for
patients presenting with a melioidosis-like syndrome.
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